Literature DB >> 8091450

Effect of graded hypothermia (27 degrees to 34 degrees C) on behavioral function, histopathology, and spinal blood flow after spinal ischemia in rat.

M Marsala1, I Vanicky, T L Yaksh.   

Abstract

BACKGROUND AND
PURPOSE: We used a rat model of reversible spinal ischemia to assess the effect of spinal cord temperature on the development of neurological and histopathologic changes after 20 minutes of reversible aortic occlusion. Spinal cord blood flow and CO2 reactivity was tested by using laser Doppler before and 60 minutes after ischemia.
METHODS: In halothane (1%)-anesthetized rats, the spinal cord temperature as assessed by using thermocouple in the paraspinal muscles was lowered to 34 degrees, 31 degrees, or 27 degrees C. After ischemia, spinal cord temperature was raised to 37 degrees C for the next 30 minutes. Animals were maintained in this normothermic condition for 8 hours, after which motor and sensory function were assessed. All animals were then anesthetized and perfused with 10% formalin for light microscopic analysis of spinal cords.
RESULTS: In normothermic animals, 20 minutes of ischemia resulted in a loss of CO2 reactivity and hind limb paraplegia with an attendant allodynia that persisted for the 8 hours of reperfusion. Even mild (34 degrees C) hypothermia resulted in significant improvement of neurological function compared with the normothermic group. In paraplegic animals, lumbosacral interneuronal pools localized primarily in laminae III through VII displayed heavy argyrophilic neurons and areas of localized necrosis. In moderate and deep hypothermic animals preservation of CO2 responsivity and complete recovery of neurological function were seen with no detectable histopathologic changes.
CONCLUSIONS: These results show that a slight decrease in spinal cord temperature in the peri-ischemic period provides significant protection as measured by histopathology and neurological function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8091450     DOI: 10.1161/01.str.25.10.2038

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

1.  Paraplegia after thoracoabdominal aortic surgery: not just assisted circulation, hypothermic arrest, clamp and sew, or TEVAR.

Authors:  Charles Acher; Martha Wynn
Journal:  Ann Cardiothorac Surg       Date:  2012-09

2.  Effect of post-ischemic hypothermia on spinal cord damage induced by transient ischemic insult in rabbits.

Authors:  Koji Tsutsumi; Toshihiko Ueda; Hideyuki Shimizu; Kenichi Hashizume; Yoshimi Iino; Shiaki Kawada
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-09

Review 3.  Hypothermic treatment for acute spinal cord injury.

Authors:  W Dalton Dietrich; Allan D Levi; Michael Wang; Barth A Green
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

4.  Temperature dependency of basal and evoked release of amino acids and calcitonin gene-related peptide from rat dorsal spinal cord.

Authors:  D M Dirig; X Y Hua; T L Yaksh
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

5.  A mouse model of ischemic spinal cord injury with delayed paralysis caused by aortic cross-clamping.

Authors:  Hamdy Awad; Daniel P Ankeny; Zhen Guan; Ping Wei; Dana M McTigue; Phillip G Popovich
Journal:  Anesthesiology       Date:  2010-10       Impact factor: 7.892

6.  Phospholipid composition in spinal cord regions after ischemia/reperfusion.

Authors:  N Lukácová; P Jalc; J Marsala
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

7.  Effect of delayed induction of postischemic hypothermia on spinal cord damage induced by transient ischemic insult in rabbits.

Authors:  Koji Tsutsumi; Toshihiko Ueda; Hideyuki Shimizu; Kenichi Hashizume; Ryohei Yozu
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2004-09

Review 8.  Mild hypothermia as a treatment for central nervous system injuries: Positive or negative effects.

Authors:  Rami Darwazeh; Yi Yan
Journal:  Neural Regen Res       Date:  2013-10-05       Impact factor: 5.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.